Search in:

Advanced search

International Journal of General Medicine Volume 3, 2010 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Case Report

Remitting–relapsing multiple sclerosis patient refractory to conventional treatments and bone marrow transplantation who responded to natalizumab

Athanasia Mouzaki1 Division of Hematology, Department of Internal MedicineCorrespondence[email protected]

Maria Koutsokera2 Neurology Clinic, Medical School and University Hospital

Zoe Dervilli1 Division of Hematology, Department of Internal Medicine

Maria Rodi1 Division of Hematology, Department of Internal Medicine

Dimitra Kalavrizioti1 Division of Hematology, Department of Internal Medicine;3 Department of Chemistry, University of Patras, Patras, Greece

Nikolaos Dimisianos2 Neurology Clinic, Medical School and University Hospital

Ioannis Matsoukas3 Department of Chemistry, University of Patras, Patras, Greece

Panagiotis Papathanasopoulos2 Neurology Clinic, Medical School and University Hospital

show all

Pages 313-320 | Published online: 23 Sep 2010

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

MouzakiATseliosTPapathanassopoulosPMatsoukasIChatzantoniKImmunotherapy for multiple sclerosis: Basic insights for new clinical strategiesCurr Neurovasc Res20041432534016181082
PubMed Web of Science ®Google Scholar
MouzakiADeraosSChatzantoniKAdvances in the treatment of autoimmune diseases; cellular activity, type-1/type-2 cytokine secretion patterns and their modulation by therapeutic peptidesCurr Med Chem200512131537155015974986
PubMed Web of Science ®Google Scholar
HedegaardCJKrakauerMBendtzenKLundHSellebjergFNielsenCHT helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosisImmunology2008125216116918397264
PubMed Web of Science ®Google Scholar
SakaguchiSNaturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-selfNat Immunol20056434535215785760
PubMed Web of Science ®Google Scholar
CostantinoCMBaecher-AllanCHaflerDAMultiple sclerosis and regulatory T cellsJ Clin Immunol200828669770618763026
PubMed Web of Science ®Google Scholar
PapanastasiouADChatzantoniKMouzakiACurrent therapeutic leads for the treatment of autoimmune diseases: Stem cell transplantation and inhibition of post-translational modifications of autoantigensExpert Opin Drug Discov200831012551265
PubMed Web of Science ®Google Scholar
FagiusJLundgrenJObergGEarly highly aggressive MS successfully treated by hematopoietic stem cell transplantationMult Scler200915222923718805841
PubMed Web of Science ®Google Scholar
ChenJTCollinsDLAtkinsHLFreedmanMSArnoldDLCanadian MS/BMT Study GroupMagnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesionsAnn Neurol200863225426218257039
PubMed Web of Science ®Google Scholar
ShevchenkoYLNovikAAKuznetsovANHigh-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosisExp Hematol200836292292818468768
PubMed Web of Science ®Google Scholar
FargeDLabopinMTyndallAAutologous hematopoietic stem cell transplantation for autoimmune diseases: An observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune DiseasesHaematologica201095228429219773265
PubMed Web of Science ®Google Scholar
LuJQStorekJMetzLContinued disease activity in a patient with multiple sclerosis after allogeneic hematopoietic cell transplantationArch Neurol200966111612019139309
PubMedGoogle Scholar
RansohoffRMNatalizumab for multiple sclerosisNew Engl J Med20073562622262917582072
PubMed Web of Science ®Google Scholar
DeraosGChatzantoniKMatsoukasMTCitrullination of linear and cyclic altered peptide ligands from myelin basic protein (MBP) epitope elicits a Th1 polarized response by T cells isolated from multiple sclerosis patients: Implications in triggering diseaseJ Med Chem200851247834784219053745
PubMed Web of Science ®Google Scholar
MuraroPADouekDCPackerAThymic output generates a new and diverse tcr repertoire after autologous stem cell transplantation in multiple sclerosis patientsJ Exp Med2005201580581615738052
PubMed Web of Science ®Google Scholar
KantorABThe development and repertoire of B-1 cells (CD5 B cells)Immunol Today199112113893911723875
PubMedGoogle Scholar
BaumgarthNTungJWHerzenbergLAInherent specificities in natural antibodies: A key to immune defence against pathogen invasionSpringer Semin Immunopathol200526434736215633017
PubMed Web of Science ®Google Scholar
LindbergRLAchtnichtsLHoffmannFKuhleJKapposLNatalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patientsJ Neuroimmunol20081941–215316418178259
PubMed Web of Science ®Google Scholar
StuveOMarraCMJeromeKRImmune surveillance in multiple sclerosis patients treated with natalizumabAnn Neurol200659574374716634029
PubMed Web of Science ®Google Scholar
StuveOMarraCMBar-OrAAltered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosisArch Neurol200663101383138717030653
PubMed Web of Science ®Google Scholar
BonigHWundesAChangK-HLucasSPapayannopoulouTIncreased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumabBlood200811173439344118195093
PubMed Web of Science ®Google Scholar
ZohrenFToutzarisDKlärnerVHartungH-PKieseierBHaasRThe monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humansBlood200811173893389518235044
PubMed Web of Science ®Google Scholar
JingDOelschlaegelUOrdemannRCD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and functionBone Marrow Transplant2010125 Epub ahead of print
Web of Science ®Google Scholar
PutzkiNBaranwalMKTettenbornBLimmrothVKreuzfelderEEffects of natalizumab on circulating B cells, T regulatory cells and natural killer cellsEur Neurol201063531131720453514
PubMed Web of Science ®Google Scholar
Carrillo-VicoALeechMDAndertonSMContribution of myelin autoantigen citrullination to T cell autoaggression in the central nervous systemJ Immunol201018462839284620164413
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Remitting–relapsing multiple sclerosis patient refractory to conventional treatments and bone marrow transplantation who responded to natalizumab

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Remitting–relapsing multiple sclerosis patient refractory to conventional treatments and bone marrow transplantation who responded to natalizumab

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date